DENTSPLY SIRONA Inc. (XRAY) › Analysis

DENTSPLY SIRONA Inc. (XRAY) analysis, February 27, 2026

Published February 27, 2026 · XRAY chart, levels and live analysis

Key Updates

DENTSPLY SIRONA rallied +5.04% to $13.45 since the February 26 report, resuming its recovery trajectory after the prior session's -2.10% consolidation. The stock has now advanced +17.63% YTD, demonstrating resilience despite the 6-month decline of -6.18%. The recovery is supported by a positive industry backdrop, with multiple market research reports confirming robust growth projections across dental equipment, consumables, and digital dentistry segments through 2031. The company maintains its position as a key market player across dental burs, periodontal treatment, bone graft substitutes, digital dentures, and general dental equipment markets, with aggregate addressable market opportunities exceeding $100 billion through 2033.

Current Trend

DENTSPLY SIRONA has established a strong YTD uptrend with +17.63% gains, recovering from the 6-month drawdown of -6.18%. The recent price action shows momentum acceleration: +5.78% over 1 day, +7.22% over 5 days, and +9.22% over 1 month. The stock at $13.45 is consolidating below the mid-February peak of approximately $14.66 (implied from previous -16.54% decline reference), establishing a near-term resistance zone. The sustained positive momentum across multiple timeframes suggests buyers are regaining control after the February correction, though the stock remains below its 6-month highs. The technical pattern indicates a recovery phase within an established uptrend, with immediate support likely near the $12.20-$12.80 range tested in recent sessions.

Investment Thesis

The investment thesis for DENTSPLY SIRONA centers on its leadership position in a structurally growing global dental market projected to reach $87.1 billion by 2033 at 5.8% CAGR. The company benefits from multiple tailwinds: (1) aging demographics driving restorative and prosthetic demand, (2) accelerating digital dentistry adoption through CAD/CAM and 3D printing technologies, (3) expanding addressable markets in dental consumables with high recurring revenue characteristics, and (4) North American market dominance where infrastructure and reimbursement support premium pricing. DENTSPLY SIRONA is explicitly named as a key player across dental burs ($1.23 billion market by 2033), periodontal treatments ($3.86 billion by 2031), bone graft substitutes ($2.04 billion by 2031), digital dentures ($2.39 billion by 2031), and dental equipment ($11.48 billion by 2031). The thesis assumes the company can maintain market share while benefiting from industry digitalization and geographic expansion, particularly in high-growth Asia Pacific markets.

Thesis Status

The investment thesis remains intact and is strengthening based on recent industry data. Seven market research reports published between February 2-25, 2026 confirm robust growth trajectories across DENTSPLY SIRONA's core product categories, with CAGRs ranging from 5.8% to 7.7% through 2031-2033. The company's explicit identification as a key market participant across five separate market segments validates its diversified revenue base and competitive positioning. North America's 38.8%-47.3% market share across various dental segments aligns with DENTSPLY SIRONA's geographic strength. However, the thesis faces near-term headwinds from competitive pressure, as evidenced by 3Shape's TRIOS 6 scanner winning the European Product Design Award 2025 with 110% higher resolution, and integration announcements like Henry Schein One connecting Align Technology's iTero scanners to practice management platforms. These developments suggest intensifying competition in digital dentistry, though they also validate the secular shift toward digital workflows that benefits established players with comprehensive portfolios.

Key Drivers

The primary catalyst supporting DENTSPLY SIRONA's recent rally is confirmation of sustained industry growth across multiple product categories. The global dental market is projected to reach $87.1 billion by 2033, driven by increasing dental disorder prevalence, cosmetic dentistry demand, and digital technology adoption. Specific subsegments show even stronger momentum: dental burs will reach $1.23 billion by 2033 at 6.3% CAGR, periodontal treatments will grow to $3.86 billion by 2031, and digital dentures will reach $2.39 billion by 2031 at 6.7% CAGR. The shift toward digital workflows is accelerating, with integration announcements between scanner manufacturers and practice management systems demonstrating ecosystem convergence. Competitive dynamics are intensifying, with 3Shape's TRIOS 6 winning design awards for 110% higher resolution scanning, pressuring established players to innovate.

Technical Analysis

DENTSPLY SIRONA at $13.45 exhibits constructive technical momentum following the +5.04% advance. The stock has established a clear YTD uptrend channel with +17.63% gains, though it remains -6.18% below 6-month highs, suggesting resistance near $14.30-$14.70. The recent price action shows acceleration across all measured timeframes: +5.78% (1d), +7.22% (5d), and +9.22% (1m), indicating strengthening buyer conviction. The February correction to approximately $12.20 established a near-term support level that held on retests, creating a potential higher-low formation. Volume patterns during the recent rally (not provided but implied by sustained gains) suggest institutional participation. Key resistance lies at the mid-February peak zone around $14.66, while support has formed at $12.80 (prior session) and $12.20 (February low). The technical setup favors continuation toward resistance testing, with a break above $14.70 potentially targeting the 6-month high recovery zone near $14.35.

Bull Case

Bear Case

Get a message when the XRAY picture changes — the agent team watches the levels and the news for you.Create a free account

More XRAY analyses